7 employees
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called
1997
$54M
from 2 investors over 2 rounds
Intercell USA, Inc. raised $54M on January 3, 2003
Investors: ProQuest Investments and Domain Associates